LabCorp Tells Albright Not To Triple $272M IP Judgment

LabCorp has urged U.S. District Judge Alan Albright not to enhance a $272 million jury verdict against it in a biotechnology company's patent suit over a testing method for genetic disorders,...

Already a subscriber? Click here to view full article